Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
New to MyHealth?
Manage Your Care From Anywhere.
Access your health information from any device with MyHealth. You can message your clinic, view lab results, schedule an appointment, and pay your bill.
ALREADY HAVE AN ACCESS CODE?
DON'T HAVE AN ACCESS CODE?
NEED MORE DETAILS?
MyHealth for Mobile
Get the iPhone MyHealth app »
Get the Android MyHealth app »
EFFECTS OF CANAGLIFLOZIN ON MAJOR ADVERSE CARDIOVASCULAR OUTCOMES IN PATIENTS WITH DIFFERENT BASELINE LEVELS OF TYPE 2 DIABETES MELLITUS DISEASE SEVERITY: RESULTS FROM THE CANVAS PROGRAM Young, T., Li, J., Kang, A., Heerspink, H., Hockham, C., Arnott, C., Neuen, B., Zoungas, S., Mahaffey, K. W., Perkovic, V., De Zeeuw, D., Fulcher, G., Neal, B., Jardine, M. OXFORD UNIV PRESS. 2020: 1351
View details for DOI 10.1093/ndt/gfaa142|iii1351
View details for Web of Science ID 000562392100140